Skip to content

Investigating the Effect of Chlorine Dioxide and Chlorhexidine Mouthwash on Bad Breath

Hyperpure Chlorine Dioxide Versus Chlorhexidine in Intra-oral Halitosis (ODOR Trial)

Status
Enrolling by invitation
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06219226
Enrollment
60
Registered
2024-01-23
Start date
2024-04-18
Completion date
2025-12-18
Last updated
2025-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Halitosis

Keywords

ClO2, mouth rinse, malodor

Brief summary

The ODOR trial will be a single-centric, double-blinded, parallel-group, double-armed pilot randomized controlled trial with a non-inferiority design. The efficacy of hyperpure chlorine dioxide will be compared to chlorhexidine mouthwash. The short-term effect of the mouthwashes will be investigated in a 3-hour-long period. The primary endpoint will be the changes in the organoleptic testing scores.

Detailed description

Eligible patients will be randomly allocated to two groups in a 1:1 ratio. Necessary data will be collected with prespecified electronic case report forms (REDCap). The statistician will calculate the sample size at the end of the pilot investigation of the first 30-30 patients. If feasible, investigators will continue the study by enrolling more patients.

Interventions

PROCEDUREChlorine dioxide mouthwash

This one rinsing will last 2x15 seconds(2x12,5ml).

PROCEDUREChlorhexidine mouthwash

This one rinsing will last 2x15 seconds(2x12,5ml).

Sponsors

Semmelweis University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Organoleptic test score (OLS)\>=2 for IOH * Patients with at least 20 teeth * 8 hours of scented oral hygiene product usage, 4 hours of eating, and 2 hours of drinking restriction * on the day of investigation, restriction of alcohol, caffeine, perfume usage, and food intake with characteristic smell

Exclusion criteria

* Medical history of systematic and infectious diseases (e.g., hepatitis, HIV, tuberculosis). * Antibiotic use within the month before the study's start or during the trial or any regular medication * Extraoral halitosis (will be distinguished by observing the nasal breath) * Eat foods (like garlic) linked to oral malodor on the day before and the sampling day, as well as wear heavily fragrant cosmetics on that day. * Patients with removable dentures * Smokers (Cigars, Cigarettes, Pipes, Chewing tobacco, e-cigarette, or vaping products used in the last month)

Design outcomes

Primary

MeasureTime frameDescription
Changes of the organoleptic testing scoresimmediately after the rinse and 3 hours later(gold standard 6-point (0-5) intensity scale. The examiner rates it 0 when the patient has no halitosis, and 5 when it is very severe)

Secondary

MeasureTime frameDescription
Changes of the volatile sulfur compoundsimmediately after the rinse and 3 hours laterwith gas chromatography
Self-perceived halitosisimmediately after the rinse and 3 hours laterwith a visual analog scale ratings (0-100, 0 = No Pain, 100 = Worst Possible Pain)

Other

MeasureTime frameDescription
Side effectsimmediately after the rinse and 3 hours later(e.g., tooth discoloration, signs of allergic reactions, subjective experiences: unpleasant taste, false taste or burning sensation, pain, changes in salivary flow)

Countries

Hungary

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026